Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F17%3A10364237" target="_blank" >RIV/00216208:11110/17:10364237 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1093/nutrit/nux047" target="_blank" >http://dx.doi.org/10.1093/nutrit/nux047</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1093/nutrit/nux047" target="_blank" >10.1093/nutrit/nux047</a>
Alternative languages
Result language
angličtina
Original language name
Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
Original language description
In recent years, there has been growing interest in the possible use of nutraceuticals to improve and optimize dyslipidemia control and therapy. Based on the data from available studies, nutraceuticals might help patients obtain theraputic lipid goals and reduce cardiovascular residual risk. Some nutraceuticals have essential lipid-lowering properties confirmed in studies; some might also have possible positive effects on nonlipid cardiovascular risk factors and have been shown to improve early markers of vascular health such as endothelial function and pulse wave velocity. However, the clinical evidence supporting the use of a single lipid-lowering nutraceutical or a combination of them is largely variable and, for many of the nutraceuticals, the evidence is very limited and, therefore, often debatable. The purpose of this position paper is to provide consensus-based recommendations for the optimal use of lipid-lowering nutraceuticals to manage dyslipidemia in patients who are still not on statin therapy, patients who are on statin or combination therapy but have not achieved lipid goals, and patients with statin intolerance. This statement is intended for physicians and other healthcare professionals engaged in the diagnosis and management of patients with lipid disorders, especially in the primary care setting.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30201 - Cardiac and Cardiovascular systems
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Nutrition Reviews
ISSN
0029-6643
e-ISSN
—
Volume of the periodical
75
Issue of the periodical within the volume
9
Country of publishing house
US - UNITED STATES
Number of pages
37
Pages from-to
731-767
UT code for WoS article
000410807500005
EID of the result in the Scopus database
2-s2.0-85031902306